Early in the beginning of the COVID-19 pandemic, scientists predicted the coronavirus would mutate slowly. They were wrong. Hundreds of thousands of viral mutations and multiple seasonal waves later, ...
The landscape of COVID-19 research continues to evolve as scientists uncover new insights about SARS-CoV-2 variants and their impact on vaccine effectiveness. This ongoing scientific journey reveals ...
Researchers have developed EVE-Vax, a computational design tool that creates synthetic SARS-CoV-2 spike proteins mimicking future immune-evading variants. These designed proteins enable early ...
The COVID-19 landscape remains dynamic, with new variants appearing and spreading across the globe. The FDA’s approval of updated mRNA vaccines in August 2024 was an important step to maintain ...
Current guidelines from the Department of Health and Human Services recommend that resistance assays be conducted in patients who have not responded to virological treatment or have sub-optimal ...
New computational modeling of avian influenza variants' immunoprotein interactions—developed by a research team at the ...
Do you remember the egg shortage of 2024? It wasn’t just a supply chain issue; it was a consequence of the H5N1 avian influenza -or bird flu- sweeping through poultry populations worldwide. While ...
While vaccines can be very effective for preventing viruses, like the influenza A virus (IAV), they are often strain-specific and prone to viral escape mutations. IAV alone is responsible for around ...